PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2026Biomolecules & Therapeutics0 citationsOpen Access

Phage Display Technology: Design, Library Construction, and Panning Strategies for Antibody Development

HYHobin Yang

Key Points

  • The aim is to evaluate phage display technology for antibody development through design, library construction, and panning strategies.
  • Review of phage display technology applications in antibody discovery.
  • Comparison of naïve, synthetic, and semi-synthetic antibody libraries.
  • Analysis of various panning strategies like solid-phase, liquid-phase, and cell-based methods.
  • Discussion of phagemid vectors and antibody fragment formats for library optimization.
  • Phage display technology is effective in discovering antigen-specific antibodies.
  • Different library formats offer unique advantages for functional diversity.
  • Panning strategies each have strengths and weaknesses in isolating functional binders.

Abstract

Phage display technology serves as a powerful in vitro platform for discovering antigen-specific antibodies, enabling the rapid identification and engineering of monoclonal antibodies for therapeutic applications. This review discusses key factors such as phagemid vector, antibody fragment formats, in-frame selection strategies, and effective library size in the context of maximizing functional diversity. Based on these factors, a detailed comparison of phage display antibody libraries is provided, including naïve, synthetic, and semi-synthetic formats, with emphasis on their distinctive features and design strategies. Furthermore, major panning strategies-solid-phase, liquid-phase, and cell-based panning-are compared, highlighting their respective strengths and limitations for isolating functional binders with regard to antigen presentation, epitope accessibility, and selection fidelity. Collectively, the refinement of library design and selection methodologies has led to the development of numerous approved antibodies, establishing phage display as a foundational technology in antibody drug discovery. Ultimately, this review aims to facilitate the effective application of phage display technology in developing antibody-based therapeutics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hobin Yang (2026) studied this question.

synapsesocial.com/papers/69a3d79dec16d51705d2deddhttps://doi.org/10.4062/biomolther.2025.158
Ask AI
Helpful
Bookmark
Share
View Full Paper